Cartesian Therapeutics, Inc. — Director's Dealing 2023

Nov 17, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cartesian Therapeutics, Inc. (RNAC)
CIK: 0001453687
Period of Report: 2023-11-13

Reporting Person: Hoge Elizabeth (10% Owner)
Reporting Person: Seven One Eight Three Four Irrevocable Trust (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3303699	Indirect
Common Stock	257739	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Non-Voting Convertible Preferred Stock	$		Common Stock (189756394)		Indirect
Series A Non-Voting Convertible Preferred Stock	$		Common Stock (14755609)		Indirect

Footnotes

F1: Shares are owned directly by Seven One Eight Three Four Irrevocable Trust (the "Trust"). The reporting person is a trustee and beneficiary of the Trust.

F2: Following the approval by the stockholder of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer ("Series A Preferred Stock") into shares of common stock of the issuer ("Common Stock"), each share of Series A Preferred Stock will be convertible into 1,000 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion.